CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Down 45.2% in September

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Free Report) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totalling 67,000 shares, a decline of 45.2% from the August 31st total of 122,300 shares. Currently, 1.6% of the company’s stock are sold short. […]

Related Keywords

Christopher Downs , Pharmaceuticals Daily , Pharmaceuticals Price Performance , Wealth Advisors , Nasdaq , Pharmaceuticals Inc , Acadian Asset Management , Renaissance Technologies , Geode Capital Management , Cns Pharmaceuticals Inc , Virtu Financial , Get Free Report , Capital Management , Cns Pharmaceuticals , Nasdaq Cnsp , Cnsp , Medical , Stocks , Options , Put , Call ,